16 search results
Lung
21DRA090: A Phase 1a/1b Study of LY3537982 Administered to Patients with KRAS G12C-Mutant Advanced Solid Tumors
Location: Lebanon
22DRA432:Randomized,Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects with Advanced or Metastatic PD-L1 High (TPS ?50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations (Tropion-Lu
Location: Lebanon
22DRA472:A Phase 1 Open-label, Multicenter, Dose-ranging Study to Investigate Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MT-6402 in Subjects with Advanced Solid Cancer That Expresses PD-L1
Location: Lebanon
22DRA773: A Randomized, Open-label Study of HLX10 plus Chemotherapy (Carboplatin-Etoposide) in comparison with Atezolizumab plus Chemotherapy in Previously Untreated US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Location: Lebanon
22RUS799: A Randomized, Double-Blind, International Multicenter, Phase III Study to Evaluate the Anti-Tumor Efficacy and Safety of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) or Placebo in Combination with Chemotherapy (Carboplatin/Cisplatin-Etoposide) and Concurrent Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer (LS_SCLC)
Location: Lebanon
A211901:Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions
Location: Lebanon, St. Johnsbury, VT
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
Location: Lebanon
D19052: Understanding Barriers and Facilitators for Lung Cancer Screening in High-Risk Populations
Location: Lebanon
D20034: REGULATORY T-CELL CLONALITY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Location: Lebanon
F20074 - NAUTIKA1: A Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Multiple Therapies in Biomarker-Selected Patients with Resectable Stages IB-III Non-Small Cell Lung Cancer
Location: Lebanon
H19095 - A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab With Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Stage I/II lymph-node negative Non-small Cell Lung Cance
Location: Lebanon
NRG-LU007 Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC:RAPTOR trial
Location: Lebanon, St. Johnsbury, VT
NRG-LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy followed by Concurrent Mediastinal Chemoradiation for locally Advanced Non-Small Cell Lung Cancer
Location: Lebanon, St. Johnsbury, VT
S1900E: A Phase II Study of AMG 510 in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-squamous Non-small Cell Lung Cancer
Location: Lebanon
S2302: PRAGMATICA - LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) plus Pembrolizumab (MK-3475; NSC 776864) versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cel
Location: Lebanon, St. Johnsbury, VT
Other Respiratory and Intrathoracic Organs
S2012 : Randomized Phase II/III Trial of first line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)
Location: Lebanon, St. Johnsbury, VT
